They identified ISG15 among the 111 transcripts that were upregulated by AIM2, compared with expression levels in AIM2-negative HCT116 cells, and reported a positive correlation between the expression of ISG15 and AIM2 in ten different IFN-γ-treated colorectal cancer cell lines [143]. The gene discussed is AIM2; the disease is colorectal cancer.